a u t u m n 2 0 0 2
Letter from Rick Doblin, Ph.D., MAPS President
A Clinical Plan for MDMA (Ecstasy)
in the Treatment of Post-Traumatic Stress Disorder (PTSD): Partnering with the FDA
Spirit and Stardust Read other issues of the MAPS Bulletin |
|
MAPS is a non-profit research and educational organization. Your support makes a difference. |
|||||||||||||||
